Aijaz Gundroo MD

Aijaz Gundroo

Aijaz Gundroo
MD

Assistant Professor of Medicine

Department of Medicine

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Internal Medicine; Nephrology; Renal Transplantation

Contact Information
Erie County Medical Center
462 Grider Street, Rm 1152
Buffalo, NY 14215
Phone: (716) 898-4803
Fax: (716) 898-3928
medagun@buffalo.edu


Patient Care

Looking for a doctor? This faculty member is affiliated with UBMD, the group comprised of practicing physicians who are also professors in the UB Jacobs School of Medicine and Biomedical Sciences.

View this faculty on UBMD


Education and Training:

  • Residency, Nephrology, University at Buffalo, Board Certified Nephrology (2007)
  • Fellowship, Geriatric, University at Buffalo (2006)
  • Fellowship, Nephrology, University at Buffalo (2005)
  • Residency, Internal Medicine Chief Resident, University at Buffalo (2003)
  • Residency, Internal Medicine, University at Buffalo (2003)
  • Residency, Internal Medicine, Al Salam Hospital (1997)
  • Residency, Internal Medicine, JVMC Hospital - University of Kashmir (1995)
  • Residency, Internal Medicine, SKIMS Hospital - University of Kashmir (1995)
  • Residency, Opthalmology, SMHS Hospital - University of Kashmir (1994)
  • Residency, Radio-Diagnosis & Imaging, SMHS Hospital - University of Kashmir (1994)
  • MBBS, Kashmir University- Government Medical College Srinagar (1993)

Employment:

  • Attending Transplant Nephrology, Erie County Medical Center (2015-present)
  • Assistant Professor of Clinical Medicine, Nephrology Department, Medicine, University at Buffalo (2006-present)
  • Director, Wende Correctional Facility Dialysis Center (2006–2017)
  • Research Associate, New York University - Department of Transplantation (1999–2000)
  • Research Associate, Rush Presbyterian - St. Luke‘s Medical Center (1998–1999)

Awards and Honors:

  • America's Top Physician Award (2007)
  • Best Outgoing Residents (Research) Award (2003)
  • 3rd Highest Score - Social and Preventative Medicine (1991)
  • Certificate of 3rd Highest Score, MBBS Part 1 (1991)
  • Honors in Pediatrics (1991)
  • Certificate of National Merit Scholarship for Outstanding Performance in State School Exam (1983)

Grants and Sponsored Research:

  • November 2006–February 2012
    EVOLVE Trial: Evaluation of Cinacalcet HCI Therapy to Lower Cardiovasclar Events
    Amgen Inc.
    Role: Co-Investigator
  • October 2013
    SONAR: Study of Diabetic Nephropathy with Atrasentan A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy
    Role: Principal Investigator
  • TRANSFORM: A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation- Advancin
    Novartis Pharmaceutical Company
    Role: Co-Investigator

Journal Articles:


Professional Memberships:

  • American Society of Nephrology
  • Medical Council of India
  • American Medical Association

Presentations:

  • "Long Term Outcomes and Challenges of a Renal Transplantation Program for Incarcerated Individuals" National Kidney Foundation (Boston 2019), National Kidney Foundation (2019)
  • "The Impact of Systematic Review of Status 7 Patients On The Kidney Transplant Waitlist" American Society of Nephrology (San Deigo, 2018), American Society of Nephrology (2018)
  • "Comparison of Carefully Measured Creatinine to Clearance (CrCl) to Estimated Glomerular Filtration Rate (eGFR) in Stable Renal Transplant Recipients." American Transplant Congress (San Deigo, 2010), American Transplant Congress (2010)
  • "Mycophenolic Acid and Metabolite Pharmacokinetics in African American (AA) and Caucasian (C) Renal Transplant Recipients Receiving Enteric Coated Mycophenolic Sodium and Mycophenolate Mofetil" American Transplant Congress (San Diego, 2010), American Transplant Congress (2010)
  • "Should the Incarcerated Be Considered for Renal Transplant?" American Transplant Congress (San Diego, 2010), American Transplant Congress (2010)
  • "Time Dependent Pharmacodynamic Responses of T Regulatory Cells in Stable African American and Caucasian Renal Transplant Recipients." American Transplant Congress (San Deigo, 2010), American Transplant Congress (2010)
  • "Alentuzumab induction followed by steroid free, low dose calcineurin inhibitor maintenance immunosuppression in Renal transplant recipients RTR’S) 2 year follow-up." American Society of Nephrology (San Deigo, 2009), American Society of Nephrology (2009)
  • "Comparison of Mycophenoliic Acid Pharmacokinetics in African American and Caucasian Renal Transplant Recipients Receiving Mycophenolate Mofetil and enteric coated Mycophenolic sodium." American Society of Nephrology (San Deigo, 2009), American Society of Nephrology (2009)
  • "Early Recovery of Cytomegalovirus (CMV) specific CD8+ T lymphocytes and decreased incidence of CMV infection in Renal transplant recipients (RtR) induced with Alemtuzumab(CAM1H)." American Society of Nephrology (San Deigo, 2009), American Society of Nephrology (2009)
  • "Aggressive Immunosuppression Benefits Post Transplant Glomerulonephritis." American Society of Transplantation (Boston, 2009), American Society of Transplantation (2009)
  • "Gender Differences in Cyclosporine Pharmacokinetics in Stable African American and Caucasian Renal Allograft Recipients." American Society of Transplantation (Boston 2009), American Society of Transplantation (2009)
  • "Effect of steroid Avoidance and Low dose Calcineuric-Inhibitor Immunosupression on progression of Chronic Allograft Nephropathy (CAN) Assessed by Surveillance Biopsy." American Society of Nephrology (Philadelpia, 2008), American Society of Nephrology (2008)
  • "Effect of Steroid Free Maintenance Protocol in the Progression of Chronic Allograft Nephropathy." American Transplant Congress (Toronto, 2008), American Transplant Congress (2008)
  • "Impact of Recurrent Lupus Nephritis in Renal Transplant Recipients." American Transplant Congress (Toronto, 2008), American Transplant Congress (2008)
  • "Cyclosporine Gender Differences with 12 hour Pharmacokinetic Analysis in Stable Renal Allograft Recipients." American Society of Nephrology (San Francisco, 2007), American Society of Nephrology (2007)
  • "Outcomes of Campath-1H [Alemtuzumab] Induction in High Risk Renal Transplant Recipients." American Society of Nephrology (San Francisco, 2007), American Society of Nephrology (2007)
  • "Outcomes Of Older Kidneys Transplanted In Young Renal Transplant Recipients." American Society of Nephrology (San Francisco, 2007), American Society of Nephrology (2007)
  • "Impact of Campath-1H (Alemtuzamab) Induction on CMV Infection in Renal Transplant Recipients." American Transplant Congress (San Francisco, 2007), American Transplant Congress (2007)
  • "Influence of Race, Sterroid Use and Renal Function on Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients." American Transplant Congress (San Francisco, 20017), American Transplant Congress (2007)
  • "Influence of Steroid Use and Gender on Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients." American Transplant Congress (San Francisco, 2007), American Transplant Congress (2007)
  • "Maintenance Steroid Free Campath-1H (Alemtuzamab) Induction Regimen Reduces Metabolic Complications." American Transplant Congrerss (San Francisco, 2007), American Transplant Congrerss (2007)
  • "One Year Results of Alemtuzumab (Campath-1H) Induction, Calcineurin Minimization Protocol in Renal Transplant Recipients Monitored by Surveillance Biopsies." American Transplant Congress (San Francisco, 2007), American Transplant Congress (2007)
  • "Impact of Gender, Race and Time on MDR-1 Gene Expression in Stable Renal Transplant Recipients." American Society for Clinical Pharmacology and Therapeutics (Anaheim, 2007), American Society for Clinical Pharmacology and Therapeutics (2007)
  • "A New Simple Formula to Estimate Creatinine Clearance in Renal Transplant Recipients with Stable Graft Function." American Transplant Congress (Boston, 2006), American Transplant Congress (2006)
  • "A Single Center Experience with Alemtuzumab (Campath) Induction Steroid Avoidance – Calcineurin Inhibitor Minimization Protocol in Renal Transplant Recipients Monitored by Surveillance Biopsies and Flow PRA." American Transplant Congress (Boston, 2006), American Transplant Congress (2006)
  • "Effect of Donor Age on Formulas Used to Estimate Creatinine Clearance in Renal Transplant Recipients." American Transplant Congress (Boston, 2006), American Transplant Congress (2006)
  • "Alemtuzumab (Campath) Induced Deceased Donor Kidney Transplant Recipients Exhibit Enhanced Recovery of Perioperative Allograft Function." American Society of Nephrology (Philadelpia, 2005), American Society of Nephrology (2005)
  • "A New Formula to Estimate Creatinine Clearance in Renal Transplant Patients with Stable Graft Function." American Transplant Congress (Seattle, 2005), American Transplant Congress (2005)
  • "A Syndrome of Worsening Hyperparathyroidism (HPT) with Hypercalcemia After Renal Transplant Treated with Cinacalcet." American Transplant Congress (Seattle, 2005), American Transplant Congress (2005)
See all (19 more)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

Erie County Medical Center
462 Grider Street, Rm 1152
Buffalo, NY 14215
Phone: (716) 898-4803
Fax: (716) 898-3928
medagun@buffalo.edu

Looking for a doctor? This faculty member is affiliated with UBMD, the group comprised of practicing physicians who are also professors in the UB Jacobs School of Medicine and Biomedical Sciences.

View this faculty on UBMD